Valuation

NVSNovartis AG

StockNYSE스위스Health careEU retail: available

10/10

Ratios vs sector

Medians of Health care companies in the same region (stocks and REITs).

Lower P/E, P/B, P/S and EV/EBIT mean cheaper; higher yields, returns and margins mean more for the price. Negative multiples (losses) are left out of the medians.
Metric	NVS	Sector median	vs median
P/E	20.0	15.6 · n=8	29% above
P/B	6.1	2.3 · n=14	163% above
P/S	—	3.5 · n=11	—
EV/EBIT	16.9	16.9 · n=7	near the median
Free-cash-flow yield	6.3%	5.0% · n=12	27% above
Dividend yield	3.25%	1.67% · n=58	94% above
Return on equity	31.0%	2.5% · n=14	1,154% above
Return on invested capital	25.0%	4.6% · n=11	441% above
Gross margin	—	66.3% · n=8	—

Value factor: 79 of 100 within the peer group. Full score breakdown →

The largest companies of the same sector and region.

Instrument	P/E	P/B	EV/EBIT	Free-cash-flow yield	Dividend yield	Smart Score
SNYSanofi	11.1	1.2	15.3	8.3%	6.1%	7/10
ALCAlcon	31.8	1.4	25.2	5.6%	0.6%	5/10
BNTXBioNTech SE	—	1.0	—	1.4%	0.0%	—/10
STESTERIS	26.3	2.9	19.8	4.4%	0.9%	7/10
ICLRICON plc	307.9	1.4	56.6	6.8%	0.0%	3/10
CRSPCRISPR Therapeutics AG	—	2.8	—	−7.6%	0.0%	1/10
ABCLAbCellera Biologics	—	4.2	—	−3.2%	0.0%	1/10
ZLABZai Lab Ltd	—	4.2	—	−5.5%	0.0%	1/10
AUPHAurinia Pharmaceuticals	7.0	3.6	—	—	0.0%	—/10
NVCRNovoCure Limited	—	4.8	—	−1.6%	0.0%	2/10

From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.

Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 31 12월 2025 · filed 04 2월 2026

여기서 계약 해지 · EU 소비자: 구매 후 14일 이내 취소 가능.